The study showed that antipsychotic medicines, which block the excessive dopamine that causes schizophrenia symptoms, interact with an entirely different cell than previously thought.
Northwestern Medicine scientists have discovered that antipsychotic drugs, crucial in treating schizophrenia, interact with different neurons than previously assumed. This breakthrough could potentially lead to more effective treatments with fewer side effects, challenging the established understanding of psychosis treatment.
- Antipsychotic drugs, used primarily in schizophrenia treatment, have been found to interact with different neurons than previously believed.
- This significant finding redefines our understanding of the neural basis for psychosis.
- The new research could pave the way for the development of more effective drugs with fewer side effects.
- Traditional research methods typically evaluate antipsychotic drug candidates on mouse behavior, but this new approach is more effective in predicting drug efficacy in humans.
- Schizophrenia, affecting 1 in 100 people, often exhibits ineffective response to current antipsychotics in more than 30% of patients with treatment-resistant schizophrenia.
- The adverse effects of current antipsychotics, such as tardive dyskinesia and parkinsonism, limit their use.
- The study first determined how antipsychotic drugs modulate the brain region causing psychosis in living animals.
- This research reveals a potential new path to develop more effective and safer drugs for schizophrenia, challenging traditional beliefs about the neural basis for psychosis.
Psychiatry Latest Posts
- 3 Key Updates on Psychopharmacology Drugs in the US
- Update on Prescribing via Telehealth: Potential Changes in the Drug Enforcement Administration’s Guidelines
- Depressive Mixed States: Diagnosis, Treatment, and Strategies
- Are You Prescribing ADHD Medication Correctly? Poison Centers See a 300% Rise in Reports Related to Possible Prescription Errors